Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients
Manuela Battaglia(Vita-Salute San Raffaele University), Maria-Grazia Roncarolo(Vita-Salute San Raffaele University)
Cited by 726
Related Papers
Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1/2A trials
|The Lancet|2020|445
Rapamycin and Interleukin-10 Treatment Induces T Regulatory Type 1 Cells That Mediate Antigen-Specific Transplantation Tolerance
|Diabetes|2006|170
A hypomorphic R229Q Rag2 mouse mutant recapitulates human Omenn syndrome
|Journal of Clinical Investigation|2007|111
An anti-CD45RO/RB monoclonal antibody modulates T cell responses via induction of apoptosis and generation of regulatory T cells
|The Journal of Experimental Medicine|2005|62